Top Markets
Coin of the day
Damora Therapeutics, Inc. Damora Therapeutics, Inc.

Damora Therapeutics, Inc.

DMRA
Rangering i aksjer #6696
Galecto, Inc. is a clinical-stage biotechnology company dedicated to pioneering... Galecto, Inc. is a clinical-stage biotechnology company dedicated to pioneering innovative small molecule therapeutics. These treatments are specifically engineered to address core biological pathways implicated in both cancer and fibrotic disorders. The firm is also actively developing small molecule inhibitors targeting galectin-3 and LOXL2. Established in 2011 by Ulf Jörgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgård Schambye, its corporate operations are based in Boston, Massachusetts.
Aksjekurs
$30.90
Sist synkronisert: 2026-08-27
Markedsverdi
$1.90B
Endring (1 dag)
1.68%
Endring (1 år)
859.63%
Land
US
Handel Damora Therapeutics, Inc. (DMRA)

Kategori

Historikk for aksjesplitt for Damora Therapeutics, Inc. (DMRA)
Aksjen Damora Therapeutics, Inc. (symbol: DMRA) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 28, 2026.
Én DMRA-aksje kjøpt før Aug 28, 2026 tilsvarer i dag 0 DMRA-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH